PL202753A1 - Sposob wytwarzania pochodnych benzimidazolu - Google Patents

Sposob wytwarzania pochodnych benzimidazolu

Info

Publication number
PL202753A1
PL202753A1 PL20275377A PL20275377A PL202753A1 PL 202753 A1 PL202753 A1 PL 202753A1 PL 20275377 A PL20275377 A PL 20275377A PL 20275377 A PL20275377 A PL 20275377A PL 202753 A1 PL202753 A1 PL 202753A1
Authority
PL
Poland
Prior art keywords
production
benzimidazole derivatives
benzimidazole
derivatives
Prior art date
Application number
PL20275377A
Other languages
English (en)
Other versions
PL107142B1 (pl
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB51426/76A external-priority patent/GB1585965A/en
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of PL202753A1 publication Critical patent/PL202753A1/pl
Publication of PL107142B1 publication Critical patent/PL107142B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL1977202753A 1976-12-09 1977-12-08 Sposob wytwarzania pochodnych pirymido/1,2-a/benzimidazolu PL107142B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB51426/76A GB1585965A (en) 1976-12-09 1976-12-09 3,4-dihydropyrimido (1,2 - )benzimidazol - 2(1h) - ones
GB3334177 1977-08-09

Publications (2)

Publication Number Publication Date
PL202753A1 true PL202753A1 (pl) 1978-10-09
PL107142B1 PL107142B1 (pl) 1980-01-31

Family

ID=26261828

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1977202753A PL107142B1 (pl) 1976-12-09 1977-12-08 Sposob wytwarzania pochodnych pirymido/1,2-a/benzimidazolu

Country Status (23)

Country Link
US (1) US4167569A (pl)
JP (1) JPS5390296A (pl)
AT (1) AT359068B (pl)
AU (1) AU514427B2 (pl)
CA (1) CA1086727A (pl)
CH (1) CH633291A5 (pl)
CS (1) CS199696B2 (pl)
DD (1) DD133330A5 (pl)
DE (1) DE2754930A1 (pl)
ES (1) ES464862A1 (pl)
FI (1) FI63577C (pl)
FR (1) FR2373543A1 (pl)
GR (1) GR65298B (pl)
HU (1) HU176540B (pl)
IE (1) IE45924B1 (pl)
IL (1) IL53507A (pl)
IT (1) IT1143729B (pl)
NL (1) NL7713658A (pl)
NO (1) NO774216L (pl)
NZ (1) NZ185823A (pl)
PL (1) PL107142B1 (pl)
SE (1) SE435385B (pl)
SU (1) SU843751A3 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE51802B1 (en) * 1979-12-03 1987-04-01 Fujisawa Pharmaceutical Co Quinazoline derivatives,processes for their preparation and pharmaceutical compositions containing them
CA1157858A (en) 1979-12-03 1983-11-29 Ikuo Ueda Quinazoline derivatives
DE3208218A1 (de) * 1982-03-06 1983-09-08 Basf Ag, 6700 Ludwigshafen Isoindolinfarbstoffe und deren verwendung
RU2453312C1 (ru) * 2010-11-10 2012-06-20 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" Средство, проявляющее антиагрегантную и антитромбогенную активности
BR112014032581A8 (pt) 2012-06-27 2018-08-14 4Sc Discovery Gmbh inibidores de bifluorodioxalano-amino-benzimidazol quinase para o tratamento de câncer, distúrbios do snc e inflamação autoimune

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3468888A (en) * 1967-04-11 1969-09-23 Smithkline Corp 2-substituted pyrimido(1,2-a) benzimidazoles
US3988340A (en) * 1975-01-23 1976-10-26 Bristol-Myers Company 6-Alkoxymethyl-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones and 7-alkoxymethyl-6-[H]-1,2,3,4-tetrahydropyrimido[2,1-b]quinazolin-2-ones
US4072679A (en) * 1976-06-15 1978-02-07 E. R. Squibb & Sons, Inc. 1,4- AND 4,10-DIHYDRO-4-OXO-PYRIMIDO (1,2-A)-benzimidazole-3-carboxylic acids, esters and amides

Also Published As

Publication number Publication date
NL7713658A (nl) 1978-06-13
PL107142B1 (pl) 1980-01-31
FR2373543A1 (fr) 1978-07-07
AU3112177A (en) 1979-06-07
FI63577B (fi) 1983-03-31
IE45924L (en) 1978-06-09
SE7713958L (sv) 1978-06-10
CA1086727A (en) 1980-09-30
GR65298B (en) 1980-08-01
ES464862A1 (es) 1979-01-01
FI63577C (fi) 1983-07-11
NZ185823A (en) 1980-08-26
FR2373543B1 (pl) 1980-05-16
IL53507A0 (en) 1978-03-10
CH633291A5 (de) 1982-11-30
IE45924B1 (en) 1982-12-29
DE2754930A1 (de) 1978-06-15
SE435385B (sv) 1984-09-24
IL53507A (en) 1981-07-31
AT359068B (de) 1980-10-27
DD133330A5 (de) 1978-12-27
JPS5390296A (en) 1978-08-08
AU514427B2 (en) 1981-02-12
NO774216L (no) 1978-06-12
HU176540B (en) 1981-03-28
IT1143729B (it) 1986-10-22
US4167569A (en) 1979-09-11
SU843751A3 (ru) 1981-06-30
ATA883677A (de) 1980-03-15
FI773724A (fi) 1978-06-10
CS199696B2 (en) 1980-07-31

Similar Documents

Publication Publication Date Title
PL195997A1 (pl) Sposob wytwarzania nowych pochodnych karboksyalkiloacyloaminokwasow
PL207337A1 (pl) Sposob wytwarzania pochodnych ftalazyny
PL196886A1 (pl) Sposob wytwarzania nowych alkilooksymow pochodnych kwasu 7-amino-tiazolilo-acetamido-cefalosporynowego
PL194291A1 (pl) Sposob wytwarzania nowych pochodnych glikozoaminy
PL100792B1 (pl) Sposob wytwarzania nowych pochodnych tienopirydyny
PL195504A1 (pl) Sposob wytwarzania nowych oksymow pochodnych kwasu 7-amino-tiazolilo-acetamido-cefalosporanowego
PL193742A1 (pl) Sposob wytwarzania pochodnych benzizotiazolonu
PL197928A1 (pl) Sposob wytwarzania nowych pochodnych kwasow omega-aminokarboksylowych
PL191647A1 (pl) Sposob wytwarzania pochodnych tienopirydyny
PL215008A1 (pl) Sposob wytwarzania pochodnych piranonu-3
PL197372A1 (pl) Sposob wytwarzania pochodnych kanamycyny
PL200685A1 (pl) Sposob wytwarzania nowych pochodnych uracylu
PL193183A1 (pl) Sposob wytwarzania nowych pochodnych 11-dezoksy-16-arylo-omega-tetranorprostaglandyny
PL196820A1 (pl) Sposob wytwarzania zwiazkow 3-chlorowcometylocefemowych-3
PL197704A1 (pl) Sposob wytwarzania nowych pochodnych indazoliloksy 4-propanoloaminy
PL200583A1 (pl) Sposob wytwarzania nowych pochodnych benzopiranu
PL200124A1 (pl) Sposob wytwarzania nowych pochodnych pirolidonu
PL198878A1 (pl) Sposob wytwarzania pochodnych 2-chlorosulfinyloazetydynonu
PL199364A1 (pl) Sposob wytwarzania nowych pochodnych benzoksycyny
PL200605A1 (pl) Sposob wytwarzania nowych pochodnych metioninoenkefaliny
PL208318A1 (pl) Sposob wytwarzania pochodnych tienopirydyny
PL197045A1 (pl) Sposob wytwarzania nowych pochodnych uracylu
PL202753A1 (pl) Sposob wytwarzania pochodnych benzimidazolu
PL197550A1 (pl) Sposob wytwarzania nowych pochodnych fenylopiperazyny
PL202660A1 (pl) Sposob wytwarzania nowych pochodnych spirooksazolidynodionu